Baxter International (BAX) vs DexCom (DXCM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
DexCom (DXCM) has outperformed Baxter International (BAX) over the past year, gaining 27.7% versus a gain of 4.7%. Over five years, DXCM leads with a -38.1% price change compared with -69.9% for BAX. DexCom is the larger company by market cap ($31.65 billion vs $12.22 billion), about 2.6 times the size.
On valuation, Baxter International trades at a lower forward P/E (11.6x vs 26.8x for DexCom). Baxter International pays a dividend yielding 0.85%, while DexCom does not currently pay one. DexCom converts more of its revenue into profit, with a net margin of 17.9% versus -8.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BAX | DXCM |
|---|---|---|
| Share price | $23.65 | $83.87 |
| Market cap | $12.22B | $31.65B |
| 1-day change | -1.36% | -0.51% |
| YTD return | +25.43% | +27.02% |
| 1-year return | +4.67% | +27.67% |
| 5-year return | -69.92% | -38.07% |
| P/E ratio (TTM) | — | 33.28 |
| Forward P/E | 11.59 | 26.82 |
| EPS (TTM) | $-1.88 | $2.52 |
| Dividend yield | 0.85% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| Revenue (latest FY) | $11.24B | $4.66B |
| Revenue growth (YoY) | +5.72% | +15.60% |
| Net income (latest FY) | $-957.00M | $836.30M |
| Gross margin | 30.05% | 60.10% |
| Operating margin | -2.74% | 19.56% |
| Net margin | -8.51% | 17.94% |
| 52-week high | $30.00 | $92.59 |
| 52-week low | $15.73 | $54.11 |
| Distance from 52-week high | -21.18% | -9.42% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +18.08% | +14.74% |
| Average volume | 6.60M | 4.44M |
| Shares outstanding | 517.00M | 377.36M |
| Employees | 37,500 | 11,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DexCom is about 2.6 times larger than Baxter International by market value ($31.65B vs $12.22B).
- DXCM has outperformed BAX by 23.0 percentage points over the past year.
- DexCom is more profitable, keeping 17.9 cents of every revenue dollar as net income versus -8.5 cents for Baxter International.
- DexCom grew revenue faster in its latest fiscal year (+15.60% vs +5.72%).
About Baxter International
BAX stock →Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Health Care · Medical/Dental Instruments · 37,500 employees
About DexCom
DXCM stock →DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application.
Health Care · Medical/Dental Instruments · 11,000 employees
BAX vs DXCM FAQ
Which is bigger, Baxter International or DexCom?
DexCom (DXCM) is larger, with a market capitalization of $31.65B compared with $12.22B for Baxter International (BAX).
Which stock has performed better over the past year, BAX or DXCM?
DXCM returned +27.67% over the past 12 months, compared with +4.67% for BAX (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Baxter International or DexCom?
Baxter International pays a dividend yielding 0.85%, while DexCom does not currently pay a regular dividend.
Are Baxter International and DexCom in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.